Meeting to be held in San Francisco on January 12 at 10 am hosted by H. C. Wainwright.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PVLA:
- BUY Rating on Palvella Therapeutics: De-Risked SELVA Phase 3 Design Positions QTORIN Rapamycin for First-in-Class MLM Approval and Compelling Risk–Reward
- Palvella Therapeutics issues update, 2026 outlook
- Wayfair upgraded, Instacart initiated: Wall Street’s top analyst calls
- Palvella Therapeutics appoints Vimal Patel as SVP, medical affairs
- Palvella Therapeutics initiated with an Outperform at Mizuho